On Monday, BioCardia Inc (NASDAQ: BCDA) was -3.15% drop from the session before settling in for the closing price of $1.27. A 52-week range for BCDA has been $1.00 – $3.20.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 40.58%. When this article was written, the company’s average yearly earnings per share was at 58.62%. With a float of $7.43 million, this company’s outstanding shares have now reached $10.61 million.
BioCardia Inc (BCDA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward BioCardia Inc stocks. The insider ownership of BioCardia Inc is 30.02%, while institutional ownership is 4.02%. The most recent insider transaction that took place on Dec 17 ’25, was worth 1,170. In this transaction President and CEO of this company bought 900 shares at a rate of $1.30, taking the stock ownership to the 267,966 shares. Before that another transaction happened on Dec 16 ’25, when Company’s President and CEO bought 200 for $1.37, making the entire transaction worth $274. This insider now owns 267,066 shares in total.
BioCardia Inc (BCDA) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.25 earnings per share (EPS) during the time that was better than consensus figure (set at -0.87) by 0.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.77% during the next five years compared to 40.58% growth over the previous five years of trading.
BioCardia Inc (NASDAQ: BCDA) Trading Performance Indicators
You can see what BioCardia Inc (BCDA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.73, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.82 in one year’s time.
Technical Analysis of BioCardia Inc (BCDA)
Compared to the last year’s volume of 0.26 million, its volume of 0.14 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 23.67%.
During the past 100 days, BioCardia Inc’s (BCDA) raw stochastic average was set at 17.83%, which indicates a significant decrease from 20.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0827 in the past 14 days, which was lower than the 0.0960 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3505, while its 200-day Moving Average is $1.8937. Nevertheless, the first resistance level for the watch stands at $1.3266 in the near term. At $1.4233, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5065. If the price goes on to break the first support level at $1.1467, it is likely to go to the next support level at $1.0635. Now, if the price goes above the second support level, the third support stands at $0.9668.
BioCardia Inc (NASDAQ: BCDA) Key Stats
There are 10,613K outstanding shares of the company, which has a market capitalization of 13.06 million. As of now, sales total 60 K while income totals -7,950 K. Its latest quarter income was 0 K while its last quarter net income were -1,480 K.
